3Clarkson A, Choonara I. Surveillance for fatal suspected adverse drug reactions in the UK[J] .Arch Dis Child,2002,87(6) :462 -466.
4Holt MP,Ju C. Mechanisms of drug- induced liver injury[ J ]. AAPS J,2006,8(1 ) :48 -54.
5Sodeman T, Bronk SF, Roberts P J, et al. Bile salts mediate hepatocyte apoptosis by increasing cell surface trafficking of fas[ J]. Am J Physiol Castroin Test Liver Physiol, 2000,278 ( 6 ) :992 - 999.
6Noe J,Kullak -Ublick GA,Jochum W. Impaired expression and function of the bile salt export pump due to three novel ABCBll mutations in intrahepatic cholestasis[J]. J Hepatol, 2005,43(3) :536 -543.
7Krauss G. Current understanding of delayed anticonvulsant hypersensitivity reactions[J]. Epilepsy Curr, 2006,6(2) :33 -37.
8Sierra NM, Garcia B, Marco J. Cross hypersensitivity syndrome between phenyto in and carbamazepine [ J ]. Pharm World Sci, 2005,27 ( 3 ) :170 - 174.
9Begriche K, Igoudjil A, Pessayre D,et al. Mitochondrial dysfunction in NASH : Causes, consequences and possible means to prevent it [ J ]. Mitochondrion,2006,6 ( 1 ) : 1 - 28.
10Betrosian A, Frantzeskaki F. Hepatotoxicity and valproate therapy [ J ].Intern Med J,2006,36( 11 ) :752 -754.
